The past several months have ushered in great change for cannabis companies, their investors, employees, consumers and service providers in the Northeast. New Jersey, New York and Connecticut have, in succession, approved adult-use cannabis programs in early 2021, adding a combined population of 33.4 million to states that have liberalized the cultivation, sale, possession and use of cannabis for adults. The adult-use cannabis market in New York is expected to exceed $4.2 billion in revenue by 2027. Once fully implemented, Governor Cuomo’s office expects more than $300 million in annual tax revenue.

Federal/State Dichotomy

Marijuana remains classified as a Schedule I controlled substance under the U.S. Controlled Substances Act of 1970, as amended, and is illegal under federal law for any purpose, and state and federal laws regarding marijuana often conflict. In mid-July, U.S. Senators Schumer, Wyden and Booker introduced, as a draft discussion piece, the wide-ranging and ambitious Cannabis Administration and Opportunity Act (CAOA), which would legalize cannabis on the federal level. The CAOA faces an uncertain future and is beyond the scope of this article, which focuses on the social equity part of New York’s cannabis program.

New York’s MRTA and Social Equity

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]